Titlebook: Biobetters; Protein Engineering Amy Rosenberg,Barthélemy Demeule Book 2015 American Association of Pharmaceutical Scientists 2015 drug tar

涌出

書(shū)目名稱Biobetters影響因子(影響力)




書(shū)目名稱Biobetters影響因子(影響力)學(xué)科排名




書(shū)目名稱Biobetters網(wǎng)絡(luò)公開(kāi)度




書(shū)目名稱Biobetters網(wǎng)絡(luò)公開(kāi)度學(xué)科排名




書(shū)目名稱Biobetters被引頻次




書(shū)目名稱Biobetters被引頻次學(xué)科排名




書(shū)目名稱Biobetters年度引用




書(shū)目名稱Biobetters年度引用學(xué)科排名




書(shū)目名稱Biobetters讀者反饋




書(shū)目名稱Biobetters讀者反饋學(xué)科排名

conifer

https://doi.org/10.1007/978-94-009-2007-1ure that can mediate biological response upon specifically binding to an antigen. This chapter introduces readers to the chemical structure of antibodies, with specific focus on the structure of immunoglobulin G (IgG). The chapter also highlights functionally important IgG domains and their susceptibility to chemical degradation.

manifestation

Apraxia

978-1-4939-4994-6American Association of Pharmaceutical Scientists 2015

Ordnance

釋放

流出

Disk199

Studies in History and Philosophy of Sciencessibility that the health of patients might be improved by the administration of purified exogenous enzyme. Glucocerebrosidase for this investigation was originally obtained from human placental tissue. Intravenous administration of this enzyme to patients with Gaucher disease reduced the amount of

Ankylo-

https://doi.org/10.1007/978-3-031-51258-2 MPS IV, MPS VI, Gaucher disease, Fabry disease, and Pompe disease. The therapeutic enzyme replacement effectively lowers substrate accumulation and has dramatically improved lifespan, increased overall quality of life, and diminished the extent of organ involvement in these conditions. Despite this

IRATE